Coherence - About the company
Coherence is a series A company based in San Francisco (United States), founded in 2022 by Ben Woodington and Elise Jenkins. It operates as a Developer of therapeutic neurotechnology managing cancer from inside the body. Coherence has raised $57.3M in funding from investors like Founders Fund, Blackbird Ventures and Artesian. The company has 78 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Alpha Tau Medical, RefleXion and Mevion Medical Systems.
Company Details
Developer of therapeutic neurotechnology managing cancer from inside the body. The company designs implantable electronics for sensing and stimulating the nervous system. It focuses on intervening in how cancer communicates within the body. The company utilizes artificial intelligence and machine learning to decode electrical signals.
- Website
- www.coherenceneuro.com/
Key Metrics
Founded Year
2022
Location
San Francisco, United States
Stage
Series A
Total Funding
$57.3M in 3 rounds
Latest Funding Round
Investors
Ranked
14th among 78 active competitors
Employee Count
33 as on Sep 30, 2026
Similar Companies
Sign up to download Coherence's company profile
Coherence's funding and investors
Coherence has raised a total funding of $57.3M over 3 rounds. Its first funding round was on Apr 28, 2023. Its latest funding round was a Series A round on Oct 22, 2026 for $*****. 14 investors participated in its latest round. Coherence has 17 institutional investors and 7 angel investors.
Here is the list of recent funding rounds of Coherence:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 22, 2026 | 9365994 | Series A | 3369982 | 6843938 | 6988677 | 7923080 |
Nov 04, 2025 | 6546382 | Seed | 9186778 | 7213640 | 1260524 | |
Apr 28, 2023 | 5889020 | Seed | 8997361 | 5133088 |
View details of Coherence's funding rounds and investors
Coherence's founders and board of directors
Founder? Claim ProfileThe founders of Coherence are Ben Woodington and Elise Jenkins. Ben Woodington is the CEO of Coherence.
Here are the details of Coherence's key team members:
- Ben Woodington: Co-Founder & CEO of Coherence.
- Elise Jenkins: Co-Founder & CTO of Coherence.
View details of Coherence's Founder profiles and Board Members
Coherence's employee count trend
Coherence has 33 employees as of Sep 26. Here is Coherence's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Coherence's Competitors and alternates
Top competitors of Coherence include Alpha Tau Medical, RefleXion and Mevion Medical Systems. Here is the list of Top 10 competitors of Coherence, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alpha Tau Medical 2015, Tel Aviv (Israel), Public | Developer of radiotherapy technique for the treatment of solid cancer tumors | $55M | 68/100 | |
2nd | RefleXion 2009, Hayward (United States), Series F | Provider of biology-guided radiotherapy system | $542M | 66/100 | |
3rd | Mevion Medical Systems 2004, Littleton (United States), Series F | Proton therapy systems for oncology | $500M | 62/100 | |
4th | ABK Biomedical 2012, Halifax (Canada), Series D | Developer of imageable embolic medical devices targeting benign and malignant hypervascular tumors | $140M | 61/100 | |
5th | Vergent Biosciences 2014, Minneapolis (United States), Series B | Developing tumor-targeted imaging agents for improved cancer surgery outcomes | $57M | 61/100 | |
6th | Manufacturer of radiation therapy systems and cancer treatment technology equipment | - | 61/100 | ||
7th | ZAP-X 2014, San Carlos (United States), Series E | Developer of gyroscopic radiosurgery platform | $196M | 60/100 | |
8th | Alpheus Medical 2014, Chanhassen (United States), Series B | Developer of Sonodynamic therapy device for brain cancer | $76.5M | 58/100 | |
9th | Cel-Sci 1983, Vienna (United States), Public | Developer of immunotherapy products for the treatment of cancer and infectious diseases | - | 53/100 | |
10th | AI-powered radiation therapy platform for cancer treatment | $4.88M | 49/100 | ||
14th | Coherence 2022, San Francisco (United States), Series A | Developer of therapeutic neurotechnology managing cancer from inside the body | $57.3M | 46/100 |
Looking for more details on Coherence's competitors? Click here to see the top ones
Coherence's Investments and acquisitions
Coherence has made no investments or acquisitions yet.
Reports related to Coherence
Here is the latest report on Coherence's sector:
News related to Coherence
Media has covered Coherence for 1 event in last 1 year.
•
OpenAI Invests in Startup Developing Brain Implants for Cancer DetectionWired•Oct 23, 2026•Coherence, OpenAI, Founders Fund
Are you a Founder ?
FAQs about Coherence
Explore our recently published companies
- HeroCheckout AI - Unfunded company
- 163waimao.com.cn - China based, Unfunded company
- Complex Projects - Vancouver based, 2017 founded, Unfunded company
- ComplyArt - Lennox Head based, Unfunded company
- Compton Tree Service - 1990 founded, Unfunded company
- Compliance and Policy Consulting - Miami based, Unfunded company
